Skip to main content
Top
Published in: Clinical Rheumatology 2/2010

Open Access 01-02-2010 | Original Article

Development of a framework for reporting health service models for managing rheumatoid arthritis

Authors: Siobhan O’Donnell, Linda C. Li, Judy King, Chantal Lauzon, Heather Finn, Theodora P. M. Vliet Vlieland

Published in: Clinical Rheumatology | Issue 2/2010

Login to get access

Abstract

The purpose of this study was to develop a framework for reporting health service models for managing rheumatoid arthritis (RA). We conducted a search of the health sciences literature for primary studies that described interventions which aimed to improve the implementation of health services in adults with RA. Thereafter, a nominal group consensus process was used to synthesize the evidence for the development of the reporting framework. Of the 2,033 citations screened, 68 primary studies were included which described 93 health service models for RA. The origin and meaning of the labels given to these health service delivery models varied widely and, in general, the reporting of their components lacked detail or was absent. The six dimensions underlying the framework for reporting RA health service delivery models are: (1) Why was it founded? (2) Who was involved? (3) What were the roles of those participating? (4) When were the services provided? (5) Where were the services provided/received? (6) How were the services/interventions accessed and implemented, how long was the intervention, how did individuals involved communicate, and how was the model supported/sustained? The proposed framework has the potential to facilitate knowledge exchange among clinicians, researchers, and decision makers in the area of health service delivery. Future work includes the validation of the framework with national and international stakeholders such as clinicians, health care administrators, and health services researchers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pincus T, O’Dell J (1999) Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 131:768PubMed Pincus T, O’Dell J (1999) Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 131:768PubMed
2.
3.
go back to reference Fries JF (2000) Current treatment paradigms in rheumatoid arthritis. Rheumatology 39(Suppl 1):30–35PubMed Fries JF (2000) Current treatment paradigms in rheumatoid arthritis. Rheumatology 39(Suppl 1):30–35PubMed
4.
go back to reference American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46:328–346CrossRef American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 46:328–346CrossRef
5.
go back to reference Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297CrossRefPubMed Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297CrossRefPubMed
6.
go back to reference Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Almazor MS, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O’Dell J, Turkiewicz AM, Furst DE, American College of Rheumatology (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762–784CrossRefPubMed Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Almazor MS, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O’Dell J, Turkiewicz AM, Furst DE, American College of Rheumatology (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762–784CrossRefPubMed
7.
go back to reference Li LC, Badley EM, MacKay C, Mosher D, Jamal S, Jones A, Bombardier C (2008) An evidence-informed, integrated framework for rheumatoid arthritis care. Arthritis Rheum 59:1171–1183CrossRefPubMed Li LC, Badley EM, MacKay C, Mosher D, Jamal S, Jones A, Bombardier C (2008) An evidence-informed, integrated framework for rheumatoid arthritis care. Arthritis Rheum 59:1171–1183CrossRefPubMed
8.
go back to reference Vliet Vlieland TPM, Zwinderman AH, Vandenbroucke JP, Breedveld FC, Hazes JMW (1996) A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. Br J Rheumatol 35:475–482CrossRefPubMed Vliet Vlieland TPM, Zwinderman AH, Vandenbroucke JP, Breedveld FC, Hazes JMW (1996) A randomized clinical trial of in-patient multidisciplinary treatment versus routine out-patient care in active rheumatoid arthritis. Br J Rheumatol 35:475–482CrossRefPubMed
9.
10.
go back to reference Campos AA, Graveline C, Ferguson JM, Lundon K, Schneider R, Laxer RM (2001) The physical therapy practitioner: an expanded role for physical therapy in pediatric rheumatology. Physiother Can 53:282–287 Campos AA, Graveline C, Ferguson JM, Lundon K, Schneider R, Laxer RM (2001) The physical therapy practitioner: an expanded role for physical therapy in pediatric rheumatology. Physiother Can 53:282–287
11.
go back to reference Davis P, Howard R, Brockway P (2001) An evaluation of telehealth in the provision of rheumatologic consults to a remote area. J Rheumatol 28:1910–1913PubMed Davis P, Howard R, Brockway P (2001) An evaluation of telehealth in the provision of rheumatologic consults to a remote area. J Rheumatol 28:1910–1913PubMed
12.
go back to reference Davis P, Howard R, Brockway P (2001) Telehealth consultations in rheumatology: cost-effectiveness and user satisfaction. J Telemed Telecare 7(Suppl 1):10–11CrossRefPubMed Davis P, Howard R, Brockway P (2001) Telehealth consultations in rheumatology: cost-effectiveness and user satisfaction. J Telemed Telecare 7(Suppl 1):10–11CrossRefPubMed
13.
go back to reference Leggett P, Graham L, Steele K, Gilliland A, Stevenson M, O’Reilly D, Wootton R, Taggart A (2001) Telerheumatology—diagnostic accuracy and acceptability to patient, specialist, and general practitioner. Br J Gen Pract 51:746–748PubMed Leggett P, Graham L, Steele K, Gilliland A, Stevenson M, O’Reilly D, Wootton R, Taggart A (2001) Telerheumatology—diagnostic accuracy and acceptability to patient, specialist, and general practitioner. Br J Gen Pract 51:746–748PubMed
14.
go back to reference Pal B, Laing H, Estrach C (1999) A cyberclinic in rheumatology. J R Coll Physicians Lond 33:161–162PubMed Pal B, Laing H, Estrach C (1999) A cyberclinic in rheumatology. J R Coll Physicians Lond 33:161–162PubMed
15.
go back to reference Pal B (1997) Telemedicine. Pilot study of telephone follow up in rheumatology has just been completed. Br Med J 314:520–521 Pal B (1997) Telemedicine. Pilot study of telephone follow up in rheumatology has just been completed. Br Med J 314:520–521
16.
go back to reference Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639CrossRefPubMed Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639CrossRefPubMed
17.
go back to reference Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group (Consolidated Standards of Reporting of Trials) (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295–309PubMed Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group (Consolidated Standards of Reporting of Trials) (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295–309PubMed
18.
go back to reference Li LC, Bombardier C (2006) Setting priorities in arthritis care: Care III Conference. J Rheumatol 33:1891–1894PubMed Li LC, Bombardier C (2006) Setting priorities in arthritis care: Care III Conference. J Rheumatol 33:1891–1894PubMed
19.
go back to reference Hochberg MC, Chang RW, Dwosh IL, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 353:498–502CrossRef Hochberg MC, Chang RW, Dwosh IL, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 353:498–502CrossRef
20.
go back to reference Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662 Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
22.
go back to reference Oandasan I, Baker GR, Barker C, Bosco D, D’Amour L, Jones S, Kimpton L, Lemieux-Charles L, Nasmith L, San Martin R, Tepper J, Way D (2006) Teamwork in healthcare: promoting effective teamwork in healthcare in Canada. Canadian Health Services Research Foundation, Ottawa Oandasan I, Baker GR, Barker C, Bosco D, D’Amour L, Jones S, Kimpton L, Lemieux-Charles L, Nasmith L, San Martin R, Tepper J, Way D (2006) Teamwork in healthcare: promoting effective teamwork in healthcare in Canada. Canadian Health Services Research Foundation, Ottawa
24.
go back to reference Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Pohjolainen T, Korpela M, Vuori K, Ilva K, Yli-Kerttula U, Jarvinen P, Leirisalo-Repo M (2007) Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial. Scand J Rheumatol 36:270–277CrossRefPubMed Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Pohjolainen T, Korpela M, Vuori K, Ilva K, Yli-Kerttula U, Jarvinen P, Leirisalo-Repo M (2007) Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial. Scand J Rheumatol 36:270–277CrossRefPubMed
25.
go back to reference Critchley S, Ball E (2007) Evaluation of the primary/secondary care interface in relation to a primary care rheumatology service. Qual Prim Care 15:33–36 Critchley S, Ball E (2007) Evaluation of the primary/secondary care interface in relation to a primary care rheumatology service. Qual Prim Care 15:33–36
26.
go back to reference Arvidsson SB, Petersson A, Nilsson I, Andersson B, Arvidsson BI, Petersson IF, Fridlund B, Petersson IF, Fridlund B (2006) A nurse-led rheumatology clinic’s impact on empowering patients with rheumatoid arthritis: a qualitative study. Nurs Health Sci 8:133–139CrossRefPubMed Arvidsson SB, Petersson A, Nilsson I, Andersson B, Arvidsson BI, Petersson IF, Fridlund B, Petersson IF, Fridlund B (2006) A nurse-led rheumatology clinic’s impact on empowering patients with rheumatoid arthritis: a qualitative study. Nurs Health Sci 8:133–139CrossRefPubMed
27.
go back to reference Nordmark B, Blomqvist P, Andersson B, Hagerstrom M, Nordh-Grate K, Ronnqvist R, Svensson H, Klareskog L (2006) A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support. Scand J Rheumatol 35:7–14CrossRefPubMed Nordmark B, Blomqvist P, Andersson B, Hagerstrom M, Nordh-Grate K, Ronnqvist R, Svensson H, Klareskog L (2006) A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support. Scand J Rheumatol 35:7–14CrossRefPubMed
28.
go back to reference Pace AV, Dowson CM, Dawes PT (2006) Self-referral of symptoms (SOS) follow-up system of appointments for patients with uncertain diagnoses in rheumatology out-patients. Rheumatology 45:201–203CrossRefPubMed Pace AV, Dowson CM, Dawes PT (2006) Self-referral of symptoms (SOS) follow-up system of appointments for patients with uncertain diagnoses in rheumatology out-patients. Rheumatology 45:201–203CrossRefPubMed
29.
go back to reference Katz S, PJJr V, Moskowitz RW, Thompson HM, Svec KH (1968) Comprehensive outpatient care in rheumatoid arthritis. A controlled study. JAMA 206:1249–1254CrossRefPubMed Katz S, PJJr V, Moskowitz RW, Thompson HM, Svec KH (1968) Comprehensive outpatient care in rheumatoid arthritis. A controlled study. JAMA 206:1249–1254CrossRefPubMed
30.
go back to reference Vliet Vlieland TP, Hazes JM (1997) Efficacy of multidisciplinary team care programs in rheumatoid arthritis. Semin Arthritis Rheum 27:110–122CrossRefPubMed Vliet Vlieland TP, Hazes JM (1997) Efficacy of multidisciplinary team care programs in rheumatoid arthritis. Semin Arthritis Rheum 27:110–122CrossRefPubMed
31.
go back to reference Yelin EH (1991) What’s inside the team care box? Is it the parts, the connections, the attention or the gestalt? J Rheumatol 18:1647–1648PubMed Yelin EH (1991) What’s inside the team care box? Is it the parts, the connections, the attention or the gestalt? J Rheumatol 18:1647–1648PubMed
33.
go back to reference Moher D, Dulberg CS, Wells GA (1996) Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272:122–124CrossRef Moher D, Dulberg CS, Wells GA (1996) Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272:122–124CrossRef
34.
go back to reference Moher D, Schulz KF, Altman DG, CONSORT (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 1:2CrossRefPubMed Moher D, Schulz KF, Altman DG, CONSORT (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 1:2CrossRefPubMed
35.
go back to reference Boutron I, Moher D, Tugwell P, Giraudeauf B, Poiraudeaug S, Nizardh R, Ravaud P (2005) A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 58:1233–1240CrossRefPubMed Boutron I, Moher D, Tugwell P, Giraudeauf B, Poiraudeaug S, Nizardh R, Ravaud P (2005) A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 58:1233–1240CrossRefPubMed
36.
go back to reference Moher D, Jones A, Lepage L, CONSORT Group (Consolitdated Standards for Reporting of Trials) (2001) Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285:1992–1995CrossRefPubMed Moher D, Jones A, Lepage L, CONSORT Group (Consolitdated Standards for Reporting of Trials) (2001) Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285:1992–1995CrossRefPubMed
37.
go back to reference Mills EJ, Wu P, Gagnier J, Devereaux PJ (2005) The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 26:480–487CrossRefPubMed Mills EJ, Wu P, Gagnier J, Devereaux PJ (2005) The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 26:480–487CrossRefPubMed
38.
go back to reference Egger M, Juni P, Bartlett C, CONSORT Group (Consolidated Standards of Reporting of Trials) (2001) Value of flow diagrams in reports of randomized controlled trials. JAMA 285:1996–1999CrossRefPubMed Egger M, Juni P, Bartlett C, CONSORT Group (Consolidated Standards of Reporting of Trials) (2001) Value of flow diagrams in reports of randomized controlled trials. JAMA 285:1996–1999CrossRefPubMed
39.
go back to reference European Commission (1997) Evaluating EU expenditure programmes. A guide. Ex post intermediate evaluation, 1st edn. Office for Official Publications of the European Communities, Luxenburg European Commission (1997) Evaluating EU expenditure programmes. A guide. Ex post intermediate evaluation, 1st edn. Office for Official Publications of the European Communities, Luxenburg
40.
go back to reference Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655CrossRefPubMed Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655CrossRefPubMed
41.
go back to reference Bowen J, Ford RC (2002) Managing service organizations: does having a “thing” make a difference. J Manage 28:447–469 Bowen J, Ford RC (2002) Managing service organizations: does having a “thing” make a difference. J Manage 28:447–469
42.
go back to reference Glasziou P, Meats E, Heneghan C, Shepperd S (2008) What is missing from descriptions of treatment in trials and reviews. Br Med J 336:1472–1474CrossRef Glasziou P, Meats E, Heneghan C, Shepperd S (2008) What is missing from descriptions of treatment in trials and reviews. Br Med J 336:1472–1474CrossRef
Metadata
Title
Development of a framework for reporting health service models for managing rheumatoid arthritis
Authors
Siobhan O’Donnell
Linda C. Li
Judy King
Chantal Lauzon
Heather Finn
Theodora P. M. Vliet Vlieland
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1298-5

Other articles of this Issue 2/2010

Clinical Rheumatology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine